home *** CD-ROM | disk | FTP | other *** search
/ Software Vault: The Diamond Collection / The Diamond Collection (Software Vault)(Digital Impact).ISO / cdr16 / med9505a.zip / M9550220.TXT < prev    next >
Text File  |  1995-03-04  |  2KB  |  31 lines
  1.        Document 0220
  2.  DOCN  M9550220
  3.  TI    Evolution of immunological abnormalities in HIV infection by vertical
  4.        transmission.
  5.  DT    9505
  6.  AU    Espanol T; Caragol I; Bertran JM; Immunology Unit, C.S. Valle Hebron,
  7.        Barcelona, Spain.
  8.  SO    Acta Paediatr Suppl. 1994 Aug;400:35-8. Unique Identifier : AIDSLINE
  9.        MED/95135016
  10.  AB    Forty-four children infected through vertical transmission, from a total
  11.        of 146 born to HIV-positive mothers, were studied. Immunological data
  12.        were analysed and compared with those of the noninfected children. Two
  13.        transmission patterns emerge from the clinical and immunological
  14.        characteristics: (i) infants infected during pregnancy with severe
  15.        immunodeficiency and clinical manifestations before the age of 1 year,
  16.        and (ii) children probably infected perinatally, who have better
  17.        clinical outcome. Immunological data are important for prognosis and
  18.        early therapeutic protocols to be established.
  19.  DE    Case-Control Studies  Child, Preschool  Comparative Study  CD4-Positive
  20.        T-Lymphocytes/IMMUNOLOGY  Disease Transmission, Vertical  Female  Human
  21.        HIV Antibodies/BLOOD/IMMUNOLOGY  HIV
  22.        Seropositivity/*IMMUNOLOGY/TRANSMISSION  IgA/BLOOD/IMMUNOLOGY
  23.        IgG/BLOOD/IMMUNOLOGY  IgM/BLOOD/IMMUNOLOGY  Infant  Interferon Type
  24.        II/BLOOD/IMMUNOLOGY  Interleukin-1/BLOOD/IMMUNOLOGY
  25.        Interleukin-2/BLOOD/IMMUNOLOGY  Mothers  Prognosis  Severity of Illness
  26.        Index  JOURNAL ARTICLE
  27.  
  28.        SOURCE: National Library of Medicine.  NOTICE: This material may be
  29.        protected by Copyright Law (Title 17, U.S.Code).
  30.  
  31.